Corrigendum to: The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma: UHRF1 regulates MEG3 in HCC (Molecular Carcinogenesis, (2016), 55, 2, (209-219), 10.1002/mc.22270);The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma

Molecular Carcinogenesis

Volumn 55, Issue 2, 2016, Pages 209-219

  Zhuo, Han ^a   Tang, Junwei ^a   Lin, Zhe ^b   Jiang, Runqiu ^a   Zhang, Xudong ^a   Ji, Jie ^a   Wang, Ping ^a   Sun, Beicheng ^a  

^a Nanjing Medical University   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Hypermethylation; Long non coding RNA

Indexed keywords

PROTEIN P53; CCAAT ENHANCER BINDING PROTEIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; LONG UNTRANSLATED RNA; MEG3 NON-CODING RNA, HUMAN; TP53 PROTEIN, HUMAN; TUMOR MARKER; UHRF1 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEG3 GENE; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE UHRF1; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; PROGNOSIS; PROMOTER REGIONS, GENETIC; RNA, LONG NONCODING; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84955200337     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.23558     Document Type: Erratum

References (31)

1. Di Bisceglie AM. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 2004; 127:S104-S107.
2. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003; 22:5093-5107.
3. El-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004; 127:S27-S34.
4. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-2576.
5. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: A new frontier of translational research?. Oncogene 2012; 31:4577-4587.
6. Lu KH, Li W, Liu XH, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer 2013; 13:461.
7. Qin R, Chen Z, Ding Y, Hao J, Hu J, Guo F. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma 2013; 60:486-492.
8. Ying L, Huang Y, Chen H, et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst 2013; 9:407-411.
9. Zhou Y, Zhang X, Klibanski A. et al. MEG3 noncoding RNA: A tumor suppressor. J Mol Endocrinol 2012; 48:R45-R53.
10. Braconi C, Kogure T, Valeri N, et al. MicroRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 2011; 30:4750-4756.
11. Yan J, Guo X, Xia J, et al. MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1. Med Oncol 2014; 31:879.
12. Katrincsakova B, Takeda H, Urbankova H, et al. Methylation analysis of the imprinted DLK1-GTL2 domain supports the random parental origin of the IGH-involving del(14q) in B-cell malignancies. Epigenetics 2009; 4:469-475.
13. Hu YC, Yang ZH, Zhong KJ, et al. Alteration of transcriptional profile in human bronchial epithelial cells induced by cigarette smoke condensate. Toxicol Lett 2009; 190:23-31.
14. Qin Y, Wang J, Gong W, et al. UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest. Oncol Rep 2014; 31:2635-2643.
15. UHRF1 is an oncogene that promotes DNA hypomethylation. Cancer Discov 2014; 4:OF9.
16. Mudbhary R, Hoshida Y, Chernyavskaya Y, et al. UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell 2014; 25:196-209.
17. Pi JT, Lin Y, Quan Q, et al. Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma. Med Oncol 2013; 30:613.
18. Qian C, Li S, Jakoncic J, Zeng L, Walsh MJ, Zhou MM. Structure and hemimethylated CpG binding of the SRA domain from human UHRF1. J Biol Chem 2008; 283:34490-34494.
19. Bostick M, Kim JK, Esteve PO, Clark A, Pradhan S, Jacobsen SE. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007; 317:1760-1764.
20. Liu X, Gao Q, Li P, et al. UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9. Nat Commun 2013; 4:1563.
21. Nishiyama A, Yamaguchi L, Sharif J, et al. Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature 2013; 502:249-253.
22. Sharif J, Muto M, Takebayashi S, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007; 450:908-912.
23. Du Z, Song J, Wang Y, et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal 2010; 3 ra80.
24. Qin W, Leonhardt H, Spada F. et al. Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1. J Cell Biochem 2011; 112:439-444.
25. Oliva J, Bardag-Gorce F, French BA, Li J, French SW. The regulation of non-coding RNA expression in the liver of mice fed DDC. Exp Mol Pathol 2009; 87:12-19.
26. Ferenci P, Fried M, Labrecque D, et al. World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): A global perspective. J Gastrointestin Liver Dis 2010; 19:311-317.
27. Gibb EA, Brown CJ, Lam WL. et al. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011; 10:38.
28. Zhou Y, Zhong Y, Wang Y, et al. Activation of p53 by MEG3 non-coding RNA. J Biol Chem 2007; 282:24731-24742.
29. McMurray EN, Schmidt JV. Identification of imprinting regulators at the Meg3 differentially methylated region. Genomics 2012; 100:184-194.
30. Qu C, Jiang T, Li Y, et al. Gene expression and IG-DMR hypomethylation of maternally expressed gene 3 in developing corticospinal neurons. Gene Expr Patterns 2013; 13:51-56.
31. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118-1127.